Teva Pharmaceutical first-quarter profit up, slightly tops estimates

Teva Pharmaceutical Industries reported on Thursday higher quarterly earnings that beat analysts' estimates by one cent due in part to the launch of several generic products in the United States. Teva, the world's largest generic drugmaker and Israel's biggest company, earned $1.22 per share excluding one-time items in the first quarter, compared with $1.12 a year earlier. Teva was forecast to earn $1.21 a share excluding items on revenue of $5.1 billion, according to Thomson Reuters I/B/E/S. The company maintained its full year 2014 earnings and revenue forecast.



via Health News Headlines - Yahoo News http://ift.tt/1nLAyMc